Navigation Links
QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
Date:5/25/2010

GERMANTOWN, Maryland and HILDEN, Germany, May 25, 2010 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has entered into an agreement with the Institute for Product Quality (ifp), pursuant to which QIAGEN has acquired all rights to 70 molecular food safety tests developed by the Berlin-based specialized laboratory center for food analysis. The transaction further strengthens QIAGEN's "Applied Testing" business segment, which also encompasses molecular testing systems for forensic applications, veterinary medicine and biodefense. No financial details were disclosed.

The tests acquired from ifp are based on the widely used real-time PCR (Polymerase Chain Reaction) technology and cover a broad range of molecular targets including genetic, bacterial, viral and other contaminants of foodstuffs. The tests can be fully automated using QIAGEN's own instruments such as the QIAsymphony and the Rotor-Gene Q. The transaction enables QIAGEN to offer complete solutions for all major applications in the food safety testing segment, covering entire workflows from the processing of primary samples to the final testing result.

"With this unique assay portfolio we are laying the foundation for a very strong position in the area of food safety testing and significantly strengthening the area of applied testing overall," said Peer Schatz, Chief Executive Officer of QIAGEN. "Applied testing represents an important growth area for our company. Here, we are focusing on select segments with a relevant market volume, a growing
'/>"/>

SOURCE Qiagen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. QIAGEN Acquires Exclusive Licence for Key PI3K gene
2. QIAGENs New Product Line, QIAsafe(R) DNA Blood, has Been Co-Developed With Biomatrica and is Based on Biomatricas SampleMatrix(R) Technology
3. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11
4. Plexus Awarded Development Contract With QIAGEN
5. QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
6. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Fourth Quarter and Year-End 2008 Financial Results Call Set for February 10
7. QIAGEN Welcomes 3,000th Employee in 20th year of U.S. Operations
8. SciQuest Announces Strategic Alliance with QIAGEN
9. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Second Quarter 2008 Financial Results Call Set for August 5
10. Webcast Alert: QIAGEN N.V. Announces First Quarter 2008 Earnings Conference Call
11. QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Fourth Quarter and Year End 2007 Earnings and 2008 Guidance Conference Call on the Web
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... July 25, 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: ... on the development and commercialization of a once-daily, oral ... gallstones, today announced financial results for the period ended ... Summary: , Reported cash and cash equivalents totaling ... at December 31, 2013.  , Reported a net ...
(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...
(Date:7/24/2014)... PARK, Calif. , July 24, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, ... webcast of a presentation to investors on Tuesday, ... p.m. PDT.  The presentation will include an overview ... To access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics ...
(Date:7/24/2014)... yet to materialise. Yet, scientists are making progress ... faster. One such approach relies on quantum dotsa ... an electric field. A new study demonstrates that ... dots (TQDs) with electrical impulses can help better ... TQDs be used as quantum information units, which ...
Breaking Biology Technology:Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4
... America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord ... ) focused on bringing the life saving ... today said it strongly supports legislation introduced in Congress ... Secretary of Health and Human Services to develop and ...
... Qutenza(TM) (NGX-4010)Identification of Impact of PHN and PDN ... /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: ... developing and commercializing novel pain management therapies, announced ... 61st Annual American Academy of Neurology (AAN) meeting ...
... N.J., April 29 Orchid Cellmark Inc., (Nasdaq: ... President and Chief Executive Officer of Orchid Cellmark, is scheduled ... Conference in New York City on Wednesday, May 13, 2008 ... overview and discuss the company,s recent and ongoing progress. A ...
Cached Biology Technology:Cord Blood America Supports Effort in Congress to Inform on Value of Umbilical Cord Blood Stem Cell Storage 2NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting 2NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting 3NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting 4NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting 5Orchid Cellmark to Present at the 2009 Bank of America Health Care Conference on May 13th 2Orchid Cellmark to Present at the 2009 Bank of America Health Care Conference on May 13th 3
(Date:7/25/2014)... is a complex congenital central nervous system disease ... the neural tubes during the embryonic phase. Many ... fecal incontinence and neurocognitive retardation. Such problems decrease ... life. Researchers at Ankara Physical Medicine and Rehabilitation ... performance in children with SB, using the Pediatric ...
(Date:7/25/2014)... shows that the age girls reach puberty is influenced by ... which parent contributes the gene. This is the first ... after birth and details of this study were published today ... first period, known as menarche, is a marker for the ... the onset of menses varies between girls, is an inherited ...
(Date:7/25/2014)... molecular testing panel developed at UPMC greatly increases ... for patients with thyroid nodules and cancer, report ... (UPCI), partner with UPMC CancerCenter., The test, available ... diagnostic testing agencies, improved the chances of patients ... according to the study published this month in ...
Breaking Biology News(10 mins):Could age of first period influence development of diseases in older women? 2Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3
... study shows that personal values that people refuse to disavow, ... in the brain than those values that are willingly sold. ... whether it,s a strong religious belief, a national identity ... process," says Gregory Berns, director of the Center for Neuropolicy ...
... Doctors and researchers of Hospital del Mar and ... describing a new pharmacological resistance to cancer. This new ... (epidermal growth factor receptor) causing resistance to treatment using ... attacks the EGFR. The study proves that, both ...
... RIKEN SPring-8 Center in Harima, Japan have clarified the ... a bacterial enzyme that offers clues on the origins ... importance to fundamental science, the findings provide key insights ... greenhouse gas hundreds of times more potent than carbon ...
Cached Biology News:The price of your soul: How the brain decides whether to 'sell out' 2The price of your soul: How the brain decides whether to 'sell out' 3Identified a cause of resistance to colon cancer treatment 2New study sheds light on evolutionary origin of oxygen-based cellular respiration 2
... genomes has allowed the development of the ... The S. enterica Typhimurium (strain LT2) genome ... 4,440 ORFs) and a plasmid, pSLT (93,939 ... have been designed to amplify all putative ...
... Twister II Microplate Handler is a ... for integrating BioTeks washers, readers and ... microplate capacity, ultimate flexibility and intuitive ... adding capacity to single devices or ...
XPLAC (S-17)...
Request Info...
Biology Products: